@nippy and @dachopper
thanks, that does make sense if MSB are amending the application for under 12s rather than under 18s (though I thought the FDAs sticking point was that the trial MSB used for the application wasn’t a randomised control trial (I realise MSB and some ODAC members thought this would not be feasible/ ethical)
anyways, I appreciate the update from you both
Ann: S&P DJI Announces March 2022 Quarterly Rebalance, page-62
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |